Aude N. Gleizes
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Evaluation of analytical performance of AQUIOS CL flow cytometer and method comparison with bead-based flow cytometry methods.
Journal: Clinical chemistry and laboratory medicine
Published: December 27, 2023
Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies.
Journal: JAMA network open
Published: July 12, 2023
Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10® to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug Antibodies.
Journal: International journal of molecular sciences
Published: July 19, 2022
Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF.
Journal: RMD open
Published: April 11, 2021
Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo.
Journal: Annals of the rheumatic diseases
Published: June 17, 2020
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
Journal: PLoS medicine
Published: January 24, 2020
A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort.
Journal: Frontiers in immunology
Published: December 16, 2019
Duration of combination therapy and risk of treatment failure in patients with inflammatory bowel disease.
Journal: Clinics and research in hepatology and gastroenterology
Published: August 29, 2019
Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach.
Journal: BMC medical research methodology
Published: June 19, 2019
Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
Journal: RMD open
Published: June 11, 2019
Low Percentage of Signal Regulatory Protein α/β+ Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients.
Journal: Frontiers in immunology
Published: July 19, 2018
Last Updated: 09/26/2026